Core Viewpoint - Shaanxi Jiahe Biotechnology Co., Ltd. has officially initiated the listing counseling record, with Guojin Securities as the counseling institution, marking its third attempt at an IPO after two previous withdrawals due to regulatory issues and concerns over financial disclosures [1][7]. Group 1: Company Background - Jiahe Biotechnology was established in 2000 and specializes in the research, production, and sales of natural plant extracts and health foods, making it one of the larger companies in this sector in China [2]. - The company has multiple production facilities, employs over 2,000 staff, and holds more than 200 authorized patents [2]. Group 2: Previous IPO Attempts - The company first attempted to list on the Shanghai Stock Exchange in December 2017 but withdrew its application shortly after [5]. - In June 2021, Jiahe shifted its focus to the ChiNext board but faced two rounds of inquiries from the exchange, leading to another withdrawal in July 2022 [7][8]. Group 3: Regulatory Challenges - In April 2023, the company faced regulatory actions due to issues identified during its previous ChiNext application, including discrepancies in financial disclosures and inventory management [1][9]. - The Shenzhen Stock Exchange highlighted significant concerns regarding the company's overseas sales and inventory, which raised questions about the accuracy of its financial statements [9][10]. Group 4: Current Listing Strategy - This time, Jiahe is adopting a more cautious approach by entering the counseling phase first, focusing on improving its governance, financial, and legal structures before formally applying for an IPO [1][13]. - The implementation of a comprehensive registration system in the A-share market has made the entry more inclusive but has also tightened the scrutiny on the authenticity and accuracy of information disclosures [1][13]. Group 5: Governance and Business Integrity - The company is controlled by its founders, who hold approximately 68% of the shares, raising concerns about governance effectiveness and independence [3][15]. - There are doubts regarding the authenticity of the company's overseas business, which previously accounted for about 80% of its sales, as regulatory investigations suggested potential sales fraud [16].

Core Insights - Guangxi Huiyan Kang Biotechnology Co., Ltd. has completed a 100,000 yuan angel round financing, attracting significant attention in the industry [2][3] - The company focuses on biotechnology research and application, particularly in natural plant extracts, functional skincare products, and health foods [2] - The funding will be utilized for product research and development, market expansion, and team building [2] Company Overview - Guangxi Huiyan Kang is headquartered in Nanning, Guangxi, and aims to provide safe, effective, and natural health products [2] - The company boasts a strong R&D team composed of multiple PhDs and Masters, enhancing its technological innovation capabilities [2] Competitive Advantage - The core competitiveness lies in its unique plant extraction technology and formula development capabilities [2] - The company has developed competitive products by leveraging local plant resources, such as a natural plant essence mask that has received positive consumer feedback [2] Future Plans - The completion of the angel round financing signifies market recognition of Huiyan Kang's growth potential [3] - The founder, Yang Xin, indicated plans to increase R&D investment, expand the product line, and enhance brand influence through online and offline sales channels [3] - The company plans to launch several new products next year across skincare and health food sectors to meet diverse consumer needs [3]

Core Viewpoint - Yatani Group (00789) experienced a significant stock price increase, rising over 48% during trading, with a current increase of 38.33% to HKD 0.142, and a trading volume of HKD 2.2969 million [1] Group 1: Strategic Partnership - Yatani Group announced a strategic cooperation agreement with Baiyunshan Weiyi, aimed at jointly developing products in the health and wellness sector and expanding market reach [1] - The collaboration will focus on innovative products in areas such as natural plant extracts, functional health products, and personal care items [1] - Both companies plan to promote the developed products and existing related products in overseas markets [1] Group 2: Business Development Strategy - The announcement aligns with Yatani Group's recent efforts to expand its sales business in beauty and health products [1] - The board believes that this strategic partnership will leverage Yatani Group's international market and sales platform advantages alongside Baiyunshan Weiyi's technical, brand, and product strengths, creating synergies [1] - This initiative is expected to enrich the company's product portfolio and enhance its core competitiveness in the health and wellness sector, opening new revenue streams [1]

Core Viewpoint - Yatani Group (00789) has seen a significant stock price increase of over 48% during trading, attributed to the announcement of a strategic cooperation agreement with Baiyunshan Weiyi to jointly develop products in the health sector [1] Group 1: Strategic Cooperation - The agreement aims to collaborate on the research and development of products in the health sector, including natural plant extracts, functional health products, and personal care items [1] - Both companies plan to market the developed products and existing related products in overseas markets [1] Group 2: Business Development Strategy - Yatani Group has been actively expanding its sales of beauty and health products in recent years, aligning with the strategic cooperation with Baiyunshan Weiyi [1] - The board believes that this partnership will leverage Yatani's international market and sales platform alongside Baiyunshan Weiyi's technology, brand, and product advantages, creating synergies [1] - This collaboration is expected to enrich Yatani's product portfolio and enhance its core competitiveness in the health sector, potentially opening new revenue streams [1]

Group 1 - The core point of the news is that Atnini Group has signed a strategic cooperation agreement with Guangzhou Baiyunshan Weiyi Industrial Co., Ltd. to jointly develop products in the health sector and expand market reach, with a cooperation period of one year [1] - The strategic cooperation will focus on joint product development in areas such as natural plant extracts, functional health products, and personal care products [1] - Baiyunshan Weiyi will provide brand marketing support, including brand strategy, trademark licensing, and technical consulting for sales and market promotion related to health products [1] Group 2 - The cooperation aligns with Atnini Group's business development strategy and long-term layout in the health industry, aiming to leverage the advantages of both companies [2] - The board believes that this strategic cooperation will enhance the product portfolio and core competitiveness in the health sector, potentially opening new revenue sources [2] - The agreement is considered beneficial for the company and its shareholders overall [2]

Group 1 - The core point of the article is that Atnini Group has signed a strategic cooperation agreement with Guangzhou Baiyunshan Weiyi Industrial Co., Ltd. to jointly develop products in the health sector and expand market reach, with a cooperation period of one year [1][2] - The strategic cooperation will focus on joint product development in areas such as natural plant extracts, functional health products, and personal care products [1] - Baiyunshan Weiyi will provide brand marketing support, including brand strategy, trademark licensing, and technical consulting for sales and market promotion related to health products [1] Group 2 - The cooperation aligns with Atnini Group's business development strategy and long-term layout in the health industry, aiming to leverage the strengths of both companies for synergistic effects [2] - This partnership is expected to enrich Atnini Group's product portfolio and enhance its core competitiveness in the health sector, potentially opening new revenue streams [2] - The board of directors believes that the agreement with Baiyunshan Weiyi is in the overall interest of the company and its shareholders [2]

Group 1 - The core point of the article is the strategic cooperation agreement signed between Yatani Group and Guangzhou Baiyunshan Weiyi Industrial Co., Ltd. to jointly develop products in the health sector and expand market reach [1][2] Group 2 - The strategic cooperation agreement is set for a duration of one year and focuses on joint product development in areas such as natural plant extracts, functional health products, and personal care products [1] - The collaboration aims to leverage Baiyunshan Weiyi's brand marketing support, including brand strategy, trademark licensing, and technical consulting for sales and market promotion [1] - This partnership aligns with the company's strategy to expand its beauty and health product sales, enhancing its core competitiveness in the health sector and opening new revenue streams [2]

Core Viewpoint - The strategic cooperation agreement between Yatani Group and Guangzhou Baiyunshan Weiyi Industrial Co., Ltd. aims to jointly develop products in the health sector and expand market reach, with a focus on innovation and international marketing support [1][2]. Group 1: Strategic Cooperation Details - The cooperation agreement is set for one year, focusing on joint research and development of products in the health sector, including natural plant extracts, functional health products, and personal care items [1]. - Baiyunshan Weiyi will provide brand marketing support, including brand strategy, trademark licensing, and technical consulting for sales and market promotion related to health products [1]. Group 2: Business Development Strategy - The partnership aligns with the company's strategy to expand its beauty and health product sales, enhancing its long-term positioning in the health industry [2]. - The board believes that this collaboration will leverage the company's international market advantages and Baiyunshan Weiyi's technical and brand strengths, creating synergies that could enrich the product portfolio and open new revenue streams [2].

本 公 告 乃 由 雅 天 妮 集 團 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」）自 願 向 本 公 司 股 東（「股 東」）及 本 公 司 潛 在 投 資 者 作 出。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Artini Holdings Limited 雅天妮集團有限公司 （於百慕達註冊成立之有限公司） （股份代號：789） 自願公告 關於與白雲山維一簽訂戰略合作協議 本 公 司 董 事（「董 事」）會（「董事會」）欣 然 公 告，於 二 零 二 五 年 九 月 十 九 日，本 公 司 與 廣 州 白 雲 山 維 一 實 業 股 份 有 限 公 司（「白雲山維一」）簽 署 了 一 份 戰 略 合 作 協 議 （「合作協議」），旨 在 共 同 研 發 大 健 康 領 域 產 品 及 拓 展 市 場（「戰略合作」）。合 作 期 限 為 一 年。 白 雲 ...

Group 1 - The 2025 China International Service Trade Fair (CIFTIS) is held in Beijing from September 10 to 14, showcasing the latest achievements and trends in the service trade sector with a theme of "Digital Intelligence Leading, Service Trade Renewed" [1] - Jiangsu's delegation includes over 170 enterprises and institutions with nearly 600 participants, emphasizing technological and intelligent applications in service trade [1] - The Jiangsu exhibition area features four main sections: cultural IP service consumption, AI + service trade, integration of service and goods trade, and a digital trade cluster, highlighting innovative explorations in new business models and technologies [1] Group 2 - The cultural IP service consumption area showcases the integration of technology and culture, with interactive experiences such as the "Dinosaur Sister" from Changzhou, which gained popularity during the "Su Super" league [2] - The AI + service trade area displays technological innovations, including a traditional Chinese medicine AI diagnosis system that generates a digital constitution report in three seconds, and a humanoid robot with lifelike facial expressions and multilingual capabilities [2] - The integration of service and goods trade area presents practical applications, such as AR glasses from Shine Reality (Wuxi) Technology Co., which maintain a leading position in global shipments, and natural plant extracts from Amway (China) showcasing the full value chain from R&D to product output [3] Group 3 - The digital trade cluster leverages the advantages of the China-Singapore digital trade cooperation pilot, demonstrating innovations in cross-border data flow and recognition, establishing a secure and efficient "digital highway" for enterprises [3] - Jiangsu has positioned itself as a significant player in service trade, with service imports and exports reaching $27.94 billion, a year-on-year increase of 10.5%, surpassing the national growth rate by 3.6 percentage points [4] - The province has created 17 national-level service trade carriers and supports enterprises in participating in over 40 domestic and international service trade exhibitions annually, driving high-quality development in service trade [4]